Schedule 13D ownership disclosure

RENEO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75974E103

Event date: 2021-04-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
19.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-21-000379
Form type
SC 13D
Filer
New Enterprise Associates 15, L.P.
CIK
CIK 1629794
Filed
Apr 23, 2021
Reporting period
Apr 13, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub